Zenas BioPharma, Inc. (ZBIO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Zenas BioPharma, Inc. (ZBIO) Company Statistics | The Fly

Zenas BioPharma, Inc.

· ZBIO

Dashboard

Financials

Ratios

Valuation

Statistics

1.744 B

+0.78%

General

Market Cap: $1.74B
Enterprise Value: $1.9B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -5972.60%
Operating Margin: -47557.30%
Net Profit Margin: -48438.40%
FCF Margin: -22597.40%
ROA: -69.03%
ROE: -189.68%
ROIC: -74.69%
Current Ratio: 9.93
Debt-to-Equity: 1.58
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 1702.71
P/FCF: —
P/B: 6.89
EV/EBITDA: -4.15

Growth

Rev 1Y: 100.00%
Rev 1Y Fwd Est: 3.83%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $1M
Gross Margin: -5972.60%
Operating Expenses: $415.85M
Operating Income: -$475.57M
Net Profit: -$484.38M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $196.58M
Working Capital: $587.98M
Total Assets: $701.69M
Net Debt: $193.02M
Total Liabilities: $454.59M
Total Equity: $247.1M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$225.97M
Cash Flow from Investing: -$309.41M
Cash Flow from Financing: $689M
Free Cash Flow: -$225.97M
Capital Expenditures: $2K